107 related articles for article (PubMed ID: 8741364)
1. [Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women].
Nishibe A; Morimoto S; Hirota K; Yasuda O; Ikegami H; Yamamoto T; Fukuo K; Onishi T; Ogihara T
Nihon Ronen Igakkai Zasshi; 1996 May; 33(5):353-9. PubMed ID: 8741364
[TBL] [Abstract][Full Text] [Related]
2. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
3. Beneficial aspect of oral estriol as hormone replacement therapy: consideration on bone and lipid metabolism.
Kika G; Izumi S; Mori A; Murano T; Suzuki T; Cai LY; Nakamura E; Goya K; Maeda H; Uchida N; Shida M
Tokai J Exp Clin Med; 2009 Sep; 34(3):92-8. PubMed ID: 21319007
[TBL] [Abstract][Full Text] [Related]
4. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
Delmas PD; Bjarnason NH; Mitlak BH; Ravoux AC; Shah AS; Huster WJ; Draper M; Christiansen C
N Engl J Med; 1997 Dec; 337(23):1641-7. PubMed ID: 9385122
[TBL] [Abstract][Full Text] [Related]
5. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
6. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants.
Holland EF; Leather AT; Studd JW
Br J Obstet Gynaecol; 1995 Mar; 102(3):238-42. PubMed ID: 7794850
[TBL] [Abstract][Full Text] [Related]
7. The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis.
Hayashi T; Ina K; Maeda M; Nomura H
Nitric Oxide; 2011 May; 24(4):199-203. PubMed ID: 21513812
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women.
Devogelaer JP; Lecart C; Dupret P; De Nayer P; Nagant De Deuxchaisnes C
Maturitas; 1998 Jan; 28(3):243-9. PubMed ID: 9571600
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
11. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.
Melis GB; Cagnacci A; Bruni V; Falsetti L; Jasonni VM; Nappi C; Polatti F; Volpe A
Maturitas; 1996 May; 24(1-2):83-90. PubMed ID: 8794438
[TBL] [Abstract][Full Text] [Related]
12. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study.
Minaguchi H; Uemura T; Shirasu K; Sato A; Tsukikawa S; Ibuki Y; Mizunuma H; Aso T; Koyama T; Nozawa S; Ohta H; Ikeda T; Kusuhara K; Ochiai K; Kato J; Kinoshita T; Tanaka K; Minagawa Y; Kurabayashi T; Fukunaga M
J Obstet Gynaecol Res; 1996 Jun; 22(3):259-65. PubMed ID: 8840712
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of continuous combined HRT on bone turnover and lipid metabolism in postmenopausal women.
Hart DM; Farish E; Fletcher CD; Barnes JF; Hart H; Nolan D; Spowart K
Osteoporos Int; 1998; 8(4):326-32. PubMed ID: 10024902
[TBL] [Abstract][Full Text] [Related]
14. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
[TBL] [Abstract][Full Text] [Related]
16. Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Yonsei Med J; 2004 Aug; 45(4):676-82. PubMed ID: 15344210
[TBL] [Abstract][Full Text] [Related]
17. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
Wimalawansa SJ
Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapy.
Fogelman I; Fordham JN; Fraser WD; Spector TD; Christiansen C; Morris SA; Fox J
Calcif Tissue Int; 2008 Aug; 83(2):85-92. PubMed ID: 18626566
[TBL] [Abstract][Full Text] [Related]
19. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
20. Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass.
Park SM; Joung JY; Cho YY; Sohn SY; Hur KY; Kim JH; Kim SW; Chung JH; Lee MK; Min YK
Eur J Clin Nutr; 2015 Mar; 69(3):361-6. PubMed ID: 25649239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
